Legal & General Group’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,713
| Closed | -$5.96K | – | 3427 |
|
|
2025
Q1 | $5.96K | Hold |
3,713
| – | – | ﹤0.01% | 3252 |
|
|
2024
Q4 | $4.68K | Hold |
3,713
| – | – | ﹤0.01% | 3339 |
|
|
2024
Q3 | $6.98K | Buy |
3,713
+580
| +19% | +$1.09K | ﹤0.01% | 3335 |
|
|
2024
Q2 | $23.2K | Buy |
3,133
+115
| +4% | +$851 | ﹤0.01% | 2962 |
|
|
2024
Q1 | $23.6K | Hold |
3,018
| – | – | ﹤0.01% | 2905 |
|
|
2023
Q4 | $15.3K | Buy |
3,018
+433
| +17% | +$2.2K | ﹤0.01% | 3135 |
|
|
2023
Q3 | $15.3K | Sell |
2,585
-558
| -18% | -$3.3K | ﹤0.01% | 3132 |
|
|
2023
Q2 | $23.3K | Buy |
+3,143
| New | +$23.3K | ﹤0.01% | 3050 |
|